It inhibits bacterial protein synthesis by hindering the bacterial transpeptidation process. It has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. The mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of the bacterial ribosome to inhibit RNA-dependent protein synthesis.

Myocardial protection, vasodilation, anti-atherosclerosis, anti-thrombosis, improvement of microcirculation, regulation of tissue repair and regeneration, anti-bacterial and anti-inflammatory, anti-tumor, and anti-oxidation

This product is a broad-spectrum antibacterial agent, with bactericidal effect at high concentrations. It has antibacterial effects on Streptococcus pneumoniae, hemolytic Streptococcus, Streptococcus viridans and some Staphylococci, Clostridium perfringens, Bacillus anthracis, Yersinia pestis, Corynebacterium diphtheriae, Clostridium tetani, Brucella, Haemophilus influenzae, Campylobacter, Vibrio cholerae, etc. It also has inhibitory effects on Rickettsia, Mycoplasma, Chlamydia, Spirochete, and some protozoa. It has better effects on Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. The mechanism of action is that the drug can specifically bind to the A position of the 30S subunit of the bacterial ribosome, preventing the connection of aminoacyl-tRNA at this position, thereby inhibiting the growth of peptide linkage and affecting the synthesis of bacterial proteins.